CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-01 | Fair Brett Chief Commercial Officer | Option exercise | +3,875 | 11,890 | ||
| 2019-02-01 | Fair Brett Chief Commercial Officer | Shares withheld for taxes | −1,308 | $6.96 | $9K | 10,582 |
| 2019-02-01 | Fair Brett Chief Commercial Officer | Option exercise · Restricted Stock Units | −3,875 | 11,625 | ||
| 2018-12-18 | Fair Brett Chief Commercial Officer | Option exercise | +1,750 | 8,513 | ||
| 2018-12-18 | Fair Brett Chief Commercial Officer | Shares withheld for taxes | −498 | $6.30 | $3K | 8,015 |
| 2018-12-18 | Fair Brett Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,750 | 1,750 | ||
| 2018-12-15 | Fair Brett Chief Commercial Officer | Option exercise | +1,013 | 7,051 | ||
| 2018-12-15 | Fair Brett Chief Commercial Officer | Shares withheld for taxes | −288 | $7.31 | $2K | 6,763 |
| 2018-12-15 | Fair Brett Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,013 | 2,025 | ||
| 2018-05-07 | Fair Brett Chief Commercial Officer | Option exercise | +4,050 | 7,191 | ||
| 2018-05-07 | Fair Brett Chief Commercial Officer | Shares withheld for taxes | −1,153 | $18.10 | $21K | 6,038 |
| 2018-05-07 | Fair Brett Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,050 | 3,038 |
Page 1 of 1 · 12 trades